自身免疫
抗原呈递
狼疮性肾炎
蛋白酶体
细胞生物学
生物
车站3
癌症研究
调节器
CD8型
细胞毒性T细胞
免疫学
化学
免疫系统
T细胞
体外
医学
磷酸化
内科学
疾病
基因
生物化学
作者
Liangfang Yao,Lei Zhou,Xuan Yang,Pei Zhang,Xiaoshuang Wang,Tianzhen Wang,Tianyuan Meng,Yanyan Xue,Xueqing Ma,Abdus Saboor Shah,Shiwang Shang,Xinglong Ma,Wei Xie,Hao Wang,Qing Fu,Yanyang Xia,Robb E. Moses,Hongyan Wang,Li Lei,Jianru Xiao
标识
DOI:10.1016/j.jaut.2019.05.010
摘要
For quite a long time, the 11S proteasome activator REGɑ and REGβ, but not REGγ, are known to control immunoproteasome and promote antigen processing. Here, we demonstrate that REGγ functions as an inhibitor for immunoproteasome and autoimmune disease. Depletion of REGγ promotes MHC class I-restricted presentation to prime CD8+ T cells in vitro and in vivo. Mice deficient for REGγ have elevation of CD8+ T cells and DCs, and develop age-related spontaneous autoimmune symptoms. Mechanistically, REGγ specifically interacts with phosphorylated STAT3 and promotes its degradation in vitro and in cells. Inhibition of STAT3 dramatically attenuates levels of LMP2/LMP7 and antigen presentation in cells lacking REGγ. Importantly, treatment with STAT3 or LMP2/7 inhibitor prevented accumulation of immune complex in REGγ−/− kidney. Moreover, REGγ−/− mice also expedites Pristane-induced lupus. Bioinformatics and immunohistological analyses of clinical samples have correlated lower expression of REGγ with enhanced expression of phosphorylated STAT3, LMP2 and LMP7 in human Lupus Nephritis. Collectively, our results support the concept that REGγ is a new regulator of immunoproteasome to balance autoimmunity.
科研通智能强力驱动
Strongly Powered by AbleSci AI